Menu

Celebrated Neuroscientist Dies

Candace Pert, who helped discover opioid receptors, has passed away at age 67.

Sep 23, 2013
Kate Yandell

THE SCIENTIST, March 2, 1998Candace Pert discovered a receptor for opioids as a graduate student, dedicated much of her scientific career to the study of therapeutic peptides, and became known in later years for her popular books on the connection between mind and body. She died unexpectedly earlier this month (September 12) at age 67. The cause of death was cardiac arrest, according to The New York Times.

Born in Manhattan, Pert studied biology at Bryn Mawr College before completing her PhD in pharmacology at Johns Hopkins University, where she made her opioid receptor discovery. She made waves by complaining that she was not included when her advisor Solomon Snyder and others received the Albert Lasker Award for the opioid receptor work.

They later reconciled, however, and upon her death Snyder told NYT in an e-mail that Pert had been “one of the most creative, innovative graduate students I had ever mentored.”

At the National Institute of Mental Health, where she worked after receiving her PhD, Pert became interested in how neurons use peptides to communicate with one another. That work led to the discovery of Peptide T, which showed promise as an HIV drug. She and her husband, immunologist Michael Ruff, formed a company called Peptide Design in 1987 meant to bring the molecule to the clinic.

Meanwhile, Pert became a professor at the Georgetown University School of Medicine and began to explore alternative medicine concepts, such as the connection between mind and body. She gave frequent public talks and authored Molecules of Emotion: The Scientific Basis Behind Mind-Body Medicine, part memoir and part treatise on peptides and mind-body communication. “She welcomed all spiritual practice into her life, and she loved all people,” Pert’s family wrote in a statement.

Pert published another popular book, Everything You Need to Feel Go(o)d, in 2006. She and Ruff started RAPID Pharmaceuticals, a company working to develop peptide therapies for multiple diseases, the following year.

Pert is survived by Ruff, her sister, three children and one grandchild.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.